| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/17/2003 | EP1183157B1 Device for applying an adhesive skin tattoo and for administering a pharmaceutical and/or cosmetic product |
| 09/17/2003 | EP1150662B1 Laminates containing an active substance for transdermal systems |
| 09/17/2003 | EP1140135B1 Cyclosporin solution |
| 09/17/2003 | EP1140013B1 Foaming antacid suspension tablets |
| 09/17/2003 | EP1100471B1 Compressed compositions comprising clarified xanthan gum |
| 09/17/2003 | EP1033973B1 Encapsulation method |
| 09/17/2003 | EP0950051B1 Micro-particulate form of a tetrahydropyridin derivative |
| 09/17/2003 | EP0941099B1 Treatment of bronchitis with diuridine tetraphosphate |
| 09/17/2003 | EP0938300B1 Substituted amylose as a matrix for sustained drug release |
| 09/17/2003 | EP0874623B1 Water activatable adhesive matrix containing amethocaine |
| 09/17/2003 | EP0792165B1 Immunogenic compositions |
| 09/17/2003 | EP0774955B1 Improved bioadhesive pharmaceutical delivery system |
| 09/17/2003 | EP0766960B1 External preparations for treating dermatoses |
| 09/17/2003 | EP0754682B9 Aminostilbazole derivative and medicine |
| 09/17/2003 | EP0739198B1 Device for administration of beneficial materials to ruminants |
| 09/17/2003 | EP0571613B1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 09/17/2003 | CN1443197A Acid-modified arabinogalactan protein composition |
| 09/17/2003 | CN1443193A Crystalline composites comprising phytosterols and phytostanols or derivatives thereof |
| 09/17/2003 | CN1443155A Compounds to treat alzheimer's disease |
| 09/17/2003 | CN1443078A Testosterone ester formulation for human use |
| 09/17/2003 | CN1443073A Process for preparing composition comprising medicinal herb extract for preventing and curing arthritis and composition thereof |
| 09/17/2003 | CN1443072A Compositions containing ascorbic acid phosphoric acid esters |
| 09/17/2003 | CN1443069A Sustained release ranolazine formulations |
| 09/17/2003 | CN1443064A Administration of thiol-based chemoprotectant compound |
| 09/17/2003 | CN1443063A Water soluble microflake through air gap and process thereof |
| 09/17/2003 | CN1442440A Binding agent of hydrophilic polymer-glutamic acid oligopeptide and medicinal molecular, composition containing said binding agent and use |
| 09/17/2003 | CN1442425A Adjuvent DC-chol, its liposome, preparation method and its use |
| 09/17/2003 | CN1442188A Cat ginseng injection liquid and its preparation method and use |
| 09/17/2003 | CN1442161A Pad for lowering blood viscous and blood fat |
| 09/17/2003 | CN1442160A Nose smelling liquid possessing aromatic, inducing resuscitation, arousing brain, raising spirit action |
| 09/17/2003 | CN1442152A Bony spur eczema ointment |
| 09/17/2003 | CN1442149A External use film forming powder for eliminating wound surface inflammation |
| 09/17/2003 | CN1442148A Daidzein drip pill and its preparation method |
| 09/17/2003 | CN1442147A Erigeron breviscapus liposome and its freeze dried powder injection fluid and preparation method |
| 09/17/2003 | CN1442145A Aspilrin slow release tablet |
| 09/17/2003 | CN1442141A Ferulic acid salt injection agent |
| 09/17/2003 | CN1442137A Crataegus leaf total flarone powder injection for treating heart and brain blood vessel disease and its preparation method |
| 09/17/2003 | CN1442133A Ultrafine fiber medicine dosage form and its preparation method |
| 09/17/2003 | CN1442132A Enteric coated article preparation containing 2-[(4-methoxy-3-methyl)-2- pyridyl] methyl sulfenyl-5-(1H-pyrrole-1-radical)-1H-benzimidazole |
| 09/17/2003 | CN1442127A Water in oil emulsified composition |
| 09/17/2003 | CN1121441C Method of detecting lung disease |
| 09/17/2003 | CN1121238C Novel cyclosporine preparation forms for oral administration of simple composition and high bio availability and process for producing them |
| 09/17/2003 | CN1121233C Dreparing process for aloe gel powder |
| 09/17/2003 | CN1121230C Applexy treating capsule |
| 09/17/2003 | CN1121226C Chinese medicine for preventing and treating iatrogenic hypercortisonism |
| 09/17/2003 | CN1121223C Freeze dried composition containing glycosphingolipid and process for producing the same |
| 09/17/2003 | CN1121222C Ointment for treating sweety feet and body odor and its preparation |
| 09/17/2003 | CN1121219C Novel process for manufacturing paroxetine solid dispersions |
| 09/17/2003 | CN1121213C Method of preparing sustained release compositions |
| 09/17/2003 | CN1121211C Detergent composition for skin |
| 09/17/2003 | CN1121208C Sunning protecting cosmetic composition based on light filing agent efficiency increasing mixture and use of same |
| 09/16/2003 | US6620814 Mixture with partially neutralized pH-dependent binder; antiarrhythmia agents; cardiovascular disorders, myocardium infarction |
| 09/16/2003 | US6620802 Methods of treating mild cognitive impairment using a glucocorticoid-specific receptor antagonist |
| 09/16/2003 | US6620797 Artificial tear composition containing a combination of three demulcents |
| 09/16/2003 | US6620795 Expressing an exogenously supplied gene in cells of the airway are disclosed. Lipid carrier-nucleic acid complexes or nucleic acid abre are prepared then delivered via aerosol or systemically to the lung abre or lung plus extrapulmonary |
| 09/16/2003 | US6620788 Enteral sorbefacients |
| 09/16/2003 | US6620782 compounds having Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or |
| 09/16/2003 | US6620781 Glycopeptide carboxy-saccharide derivatives |
| 09/16/2003 | US6620617 Gene encapsulated in polymer; sustained release |
| 09/16/2003 | US6620439 Chrono delivery formulations and method of use thereof |
| 09/16/2003 | US6620438 Arylglycinamide derivatives |
| 09/16/2003 | US6620435 Compositions for topical application of therapeutic agents |
| 09/16/2003 | US6620434 Sustained release dosage form unit having latex coating and method of making the same |
| 09/16/2003 | US6620433 Dispersible and soluble galenic paracetamol formulation, method for its preparation and its applications |
| 09/16/2003 | US6620432 In admixture with erodible matrix, for reliable controlled release of phenytoin sodium even after storage |
| 09/16/2003 | US6620431 Shellac film coatings providing release at selected pH and method |
| 09/16/2003 | US6620430 Plaster containing felbinac |
| 09/16/2003 | US6620429 Free active substance base is liberated, during the manufacture of the system, from active substance salts by conversion with a basic alkaline metal salt |
| 09/16/2003 | US6620428 Oral route is hampered by a low bioavailability of the drug due to an extensive first-pass metabolism and side effects such as nausea and skin disorders, like rash |
| 09/16/2003 | US6620426 Tablet coating composition |
| 09/16/2003 | US6620423 Ropivacaine for use as an analgesic in the treatment of muskuloskeletal pain |
| 09/16/2003 | US6620422 Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period |
| 09/16/2003 | US6620420 Cosmetic or dermatological application |
| 09/16/2003 | US6620407 Solid polymer particles having hydrophilic and lipophilic properties |
| 09/16/2003 | US6620405 Delivery of hydrogel compositions as a fine mist |
| 09/16/2003 | US6620404 Gaseous ultrasound contrast media and method for selecting gases for use as ultrasound contrast media |
| 09/16/2003 | US6620351 Method of forming nanoparticles and microparticles of controllable size using supercritical fluids with enhanced mass transfer |
| 09/16/2003 | US6620194 Drug coating with topcoat |
| 09/16/2003 | US6620151 Non-constant pressure infusion pump |
| 09/16/2003 | CA2329875C Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
| 09/16/2003 | CA2267096C Pharmaceutical microspheres of valproic acid for oral administration |
| 09/16/2003 | CA2226176C Hydrogel patch |
| 09/16/2003 | CA2215980C Cholesterol lowering food product containing dietary fiber encapsulated in zein |
| 09/16/2003 | CA2172493C Use of angiotensin iii and analogs thereof in tissue repair |
| 09/16/2003 | CA2119463C Glial cell line-derived neutrophic factor |
| 09/16/2003 | CA2108288C Liposomal cyclosporin formulation and process for the preparation thereof |
| 09/16/2003 | CA2037575C N-(4-piperidinyl) (dihydrobenzofuran or dihydro-2h-benzopyran) carboxamide derivatives |
| 09/13/2003 | CA2421488A1 Method for reconstituting lyophilized proteins |
| 09/12/2003 | WO2003074693A1 Dna nanocage by self-organization of dna and process for producing the same, and dna nanotube and molecule carrier using the same |
| 09/12/2003 | WO2003074622A1 Refrigerant compositions, refrigerant auxiliary compositions and uses thereof |
| 09/12/2003 | WO2003074586A1 Compound of hydrophilic polymer-polycarboxyl oligopeptide and medicines, medical composite comprising above compound and use of above compound in medicimes |
| 09/12/2003 | WO2003074537A1 Compounds for use as surfactants |
| 09/12/2003 | WO2003074527A1 Crystalline polymorphic form of irinotecan hydrochloride |
| 09/12/2003 | WO2003074474A2 Multiple-component solid phases containing at least one active pharmaceutical ingredient |
| 09/12/2003 | WO2003074469A1 Novel cinnamate salts, method for production and use thereof as medicaments |
| 09/12/2003 | WO2003074370A2 Improved liquid foaming soap compositions and dispensing system therefor |
| 09/12/2003 | WO2003074121A1 Flow condition sensor for infusion device |
| 09/12/2003 | WO2003074098A1 Modified phosphocalcic compound, injectable composition containing same |
| 09/12/2003 | WO2003074086A1 Liquid matrix undergoing phase transfer in vivo and liquid oral preparations |
| 09/12/2003 | WO2003074085A1 Tablets quickly disintegrating in oral cavity |